Anabol 1 (Anastrozole 1 mg)

Anabol 1 (Anastrozole 1 mg) is Evolve Biolabs' third-generation aromatase inhibitor, supplied as 50 tablets in sealed blister strips. Each tablet carries a full 1 mg dose of anastrozole, the active compound behind Arimidex, and the pack is built around precise, repeatable oestrogen control.

What Anabol 1 Is

Anastrozole belongs to the non-steroidal class of aromatase inhibitors. It binds the aromatase enzyme reversibly and with high affinity, blocking the conversion of androgens such as testosterone into oestradiol. Because the block is competitive rather than permanent, enzyme activity recovers once the compound clears. Anabol 1 packages that molecule at the clinical 1 mg strength, with 50 tablets per box and a blister layout that keeps every dose sealed until it is needed.

The History of Anastrozole

Anastrozole was developed by Zeneca and approved in 1995 as Arimidex for advanced breast cancer in postmenopausal women. It became a landmark endocrine drug when the ATAC programme compared it with tamoxifen in early breast cancer and reported improved disease-free survival. That result moved aromatase inhibitors from second-line options to first-line therapy and made anastrozole one of the most prescribed hormonal agents in oncology. Decades later it is still a reference compound in oestrogen-suppression research.

How It Works

The enzyme aromatase converts androstenedione and testosterone into oestrone and oestradiol. Anastrozole occupies the enzyme's active site and prevents that conversion, lowering circulating oestrogen in peripheral tissue, particularly fat and muscle. Reduced oestrogen removes negative feedback on the pituitary, so gonadotropins can rise. The drug is well absorbed orally, metabolised in the liver and cleared mainly in urine, with a terminal half-life of roughly 40 to 50 hours.

What the Research Shows

• The ATAC trial established anastrozole as superior to tamoxifen for disease-free survival in early breast cancer.
• Adjuvant studies show sustained reductions in circulating oestradiol at standard doses.
• Long-term follow-up has documented effects on bone mineral density and lipid profiles.
• Comparative work distinguishes reversible non-steroidal inhibition from irreversible steroidal inactivation.

Research Context

Anastrozole is frequently used as the comparator in studies of newer aromatase inhibitors. Because it is reversible, the degree of suppression tracks plasma concentration, which makes it easier to model than suicide inhibitors such as exemestane. Researchers have also examined the interaction between profound oestrogen suppression and bone turnover, and those findings shape how long-term oestrogen control is evaluated. The compound's clean pharmacokinetics and wide clinical record keep it at the centre of endocrine research design.

Strength, Pack and Authentication

Each tablet contains 1 mg of anastrozole USP, with 50 tablets per pack. The tablets are sealed in moisture-resistant blister strips inside a printed, tamper-evident carton that lists the active ingredient, strength and tablet count. A verification code on the packaging allows the pack to be checked against Evolve Biolabs' records, and the blister format protects each dose from moisture and handling.

Buying Anabol 1 Online

Anabol 1 is one of the most searched aromatase inhibitors in the Evolve Biolabs range. If you are researching anastrozole, comparing 1 mg Arimidex-style products or looking to buy Anabol 1 online from a verified Evolve Biolabs supplier, this page gives you the full specification, pack size, price and live stock status. Browse more Evolve Biolabs hormone-support products at NotNatty.